Exforge HCT 10 mg/160 mg/25 mg, Filmtabletten - 98 Tablette(n) Swissmedic Key 59407012 Registration Holder Novartis Pharma Schweiz AG Name Exforge HCT 10 mg/160 mg/25 mg, Filmtabletten Date of registration 16.09.2009 Original/Generic Original Introduction of Sequence 16.09.2009 ATC-Classification Valsartan, Amlodipine and Hydrochlorothiazide (C09DX01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 76.88 Limitation Yes Limitation text
Deductible 20 % Consumer price 98.65 Feedback FB GTIN 7680594070127 Medication Code Synthetika Pharmacode 4367447 Disponibility
Composition amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Amlodipine 10 mg Hydrochlorothiazide 25 mg Valsartan 160 mg
BAG: Active Agent Dose Amlodipine 10 mg Hydrochlorothiazide 25 mg Valsartan 160 mg
Inactive agents Dose additional_information (Flavum) Cellulosum Microcristallinum Crospovidonum E 172 color. Hypromellosum Überzug Macrogol 4000 Magnesii Stearas Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 05.09.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
